Marker Therapeutics Inc. (MRKR)
MRKR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9249
-8.43% on the day
Market cap
$15.4M
Nano cap
Revenue · 2025
$3.5M
No prior year to compare
Net income · 2025
-$12.2M
-343.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1094038/000110465926031274/0001104659-26-031274-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | MRKR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001094038 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.5M |
| Net income | -$12.2M |
| Operating income | -$12.9M |
| Net margin | -343.0% |
| Operating margin | -363.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $16.1M |
| Total assets | $19.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 4.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2025-08-05 |
| Latest annual report | 10-K | 2026-03-18 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-05-04 |
| Latest proxy | DEFA14A | 2026-03-20 |
Source: SEC EDGAR submissions feed, 903 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DARE | Dare Bioscience Inc. | $0.7477 | -0.32% | $14.7M |
| PTN | Palatin Technologies Inc. | $8.19 | -4.21% | $14.6M |
| NCEL | NewcelX Ltd. | $2.84 | -2.20% | $16.4M |
| RKTO | Rocket One Inc. | $0.5708 | -4.85% | $14.2M |
| KTTA | Pasithea Therapeutics Corp. | $0.4238 | -5.30% | $14.2M |
| TVRD | Tvardi Therapeutics Inc. | $1.04 | -1.89% | $13.9M |
| ALLR | Allarity Therapeutics Inc. | $0.8699 | +1.14% | $13.8M |
| HIND | Vyome Holdings Inc. | $1.97 | -1.99% | $13.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier